Singulex
Edit

Singulex

http://www.singulex.com/
Last activity: 26.09.2013
Categories: CommerceDevelopmentDiagnosticsMeasurementPlatformTechnology
Singulex is a commercial stage company pioneering Next Generation Immunodiagnostics (NGI). Singulex's proprietary Single Molecule Counting technology is the backbone of NGI, and provides unprecedented ultra-sensitivity in the precision measurement of biomarkers.
Website visits
8.4K /mo.
Mentions
5
Location: United States, California, Alameda
Employees: 51-200
Total raised: $84.5M
Founded date: 1997

Investors 3

Funding Rounds 3

DateSeriesAmountInvestors
26.09.2013-$55M-
14.01.2009-$19M-
20.09.2006-$10.5M-

Mentions in press and media 5

DateTitleDescriptionSource
26.09.2013Singulex Closes $55M FinancingSingulex, Inc., a Alameda, CA-based provider of Single Molecule Counting (SMC™) technology for scien...finsmes.co...
14.01.2009Singulex lands $19M for diagnostic systemsSingulex, an Alameda, Calif.-based biotech firm, just raised $19 million in fifth-round funding to c...venturebea...
08.06.2007Biomarker diagnostics company Singulex raises $19MSee our story here at VentureBeat LifeSciences. VentureBeat VentureBeat's mission is to be a digita...venturebea...
07.06.2007Biomarker-diagnostics developer Singulex validates $19MHayward, Calif.-based Singulex, a developer of sensitive molecular-detection systems, raised $19 mil...venturebea...
20.09.2006Molecular detection Co., Singulex, raises $10.5MSingulex, a Hayward company developing “bio-markers” to detect the presence in the body of certain p...venturebea...

Reviews 0

Sign up to leave a review

Sign up Log In